Related Experiment Video
Updated: Jun 28, 2026

08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
[Leukemoid reaction in extremely immature preterm infants]
J Wirbelauer1, W Thomas, C Siauw
1Universitäts-Kinderklinik Würzburg, Neonatologie und neonatologische Intensivmedizin, Würzburg. wirbelauer_j@klinik.uni-wuerzburg.de
Zeitschrift Fur Geburtshilfe Und Neonatologie
|October 29, 2008
Summary
Extremely premature infants rarely experience high white blood cell counts. A rare case of leukemoid reaction in a preterm infant highlights the need for cautious, individualized treatment approaches.
Area of Science:
- Neonatalogy
- Hematology
- Pediatrics
Background:
- Leukemoid reactions, characterized by extremely high white blood cell counts, are uncommon in extremely immature preterm infants.
- The precise pathogenesis of non-malignant leukemoid reactions in this population requires further elucidation.
- Potential triggers include prenatal corticosteroids, chorioamnionitis, funisitis, and systemic infections.
Observation:
- A retrospective review screened infants with gestational age <26 weeks for leukocytosis between 2006-2007.
- One case presented with a leukocyte count of 229,300/microL at 48 hours of life, persisting for three weeks.
- No impairment of microcirculation or organ dysfunction was noted in this infant.
Findings:
- Extremely immature preterm infants can develop profound leukocytosis without apparent malignant causes.
- The observed leukocytosis did not lead to secondary complications like organ dysfunction or microcirculatory impairment.
- This case suggests non-malignant leukemoid reactions may have a different clinical significance in this specific patient group.
Implications:
- Standard interventions for hyperleukocytosis in malignant conditions may not be directly applicable to extremely preterm infants.
- Therapeutic decisions for leukemoid reactions in this population should be individualized and approached with caution.
- Further research is needed to understand the long-term outcomes and optimal management strategies for non-malignant leukemoid reactions in extremely preterm infants.
Related Concept Videos
Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
